Abstract
IntroductionPeganum harmala L. (P. harmala) is broadly used in folk medicine for the treatment of various diseases including cancer. The seeds in particularly are employed for therapeutic purposes. The present paper investigates the cytotoxic effects of raw alkaloid extracts from different parts of P. harmala including fruits (TAFr), seeds (TASe), roots (TAR) and aerial parts (TAAp); in order to assess traditional claims about the therapeutic potential of this plant. MethodsThe cytotoxic effects were evaluated on six malignant cancer cells (A549, U373, Hs683, MCF7, B16F10 and SKMEL-28; A549, U373, MCF7 and SKMEL-28 which are resistant to proapoptotic stimuli) by MTT assay and quantitative videomicroscopy analysis. The main alkaloids were quantified by HPLC in the different parts of plant. ResultsTotal alkaloids of the different parts were cytotoxic towards practically all cancer cell lines with IC50 ranging 1–52μg/mL after 72 h of treatment. Videomicroscopy analysis indicated that the TAFr, TASe and TAR alkaloids affect A549 lung carcinoma cells behaviour and induce a cytostatic effect whereas TAAp extract was cytotoxic rather than cytostatic. TAAp, TAFr, TASe and TAR treatment induced global growth ratio indexes (GGR) of 0.19, 0.26, 0.3 and 0.62, respectively, after 72h of treatment. Depending on the organe, harmine, harmaline, harmol and vasicine these range between 2 and 90% w/w of the total alkaloids. ConclusionThese data indicate that P. harmala alkaloids extract may support the traditional claims regarding its anticancer uses which could be helpful in providing of new cytotoxic agents against chemo-resistant cancer cells.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
